All News
Antibiotics Fail to Treat Chronic Symptoms of Lyme Disease
(Reuters Health) - Twelve weeks of antibiotic therapy proved ineffective at combating the long-term symptoms seen in some people who have had Lyme disease, a new test of 280 sufferers found. (Citation source http://buff.ly/1Rs21R5)
Read Article1 in 2 Americans Have Musculoskeletal Conditions
A recent report from the United States Bone and Joint Initiative (USBJI) estimates that 126.6 million Americans (one in two adults) are affected by a musculoskeletal (MSK) condition; a number on par with the number of Americans living with a chronic lung or heart conditions.
Read ArticleHigh Mortal Risk in Rheumatoid Arthritis Following Arthroplasty
Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI fatality compared with the general population. At issue is whether this applies to those undergoing a surgical procedure.
Read ArticleBiologics Are Safe When Used During Pregnancy in IBD
This is a reposting of an earlier report on RheumNow that includes additional commentary from Dr. Sunada Kane, a gastroenterologist at the Mayo Clinic who specializes in both inflammatory bowel disease (IBD) and pregnancy.
Read ArticleThe Increasing and Disappointing P Value
In the March 15th issue of JAMA, Chavalarias and coworkers describe the evolution of the “P value” and its use in biomedical research in the last 25 years. (CItation Source http://buff.ly/22L0pG7)
Read ArticleIncreasing Polypharmacy and Drug Interactions in Seniors
Qato and colleagues have published in JAMA a cohort study that examined the use of both prescription and over-the-counter medications among older adults and the frequency of major drug-drug interactions. The study shows the elderly are especially at risk, and the situation is
Read ArticleFirst Head-to-Head TNF Trial Ends in a Draw
Comparative efficacy trials may be the best way to make informed treatment choices in a sea of treatment options for rheumatoid arthritis (RA). Recent years have seen impressive head-to-head (H2H) clinical trials for RA, including AMPLE (abatacept vs.
Read ArticleFDA Approves Taltz for Psoriasis
Tuesday the FDA approved the IL-17 inhibitor, Taltz (ixekizumab) for adults with moderate to severe plaque psoriasis. (Citation source http://buff.ly/1py10wd)
Read ArticleBisphosphonate Use Falls Following FDA Warnings
In the current issue of JBMR, Kim and colleagues from Brigham and Women's Hospital in Boston assessed US claims data and studied the impact of three FDA drug safety warnings regarding the use of bisphosphonates.
Read ArticleAcetaminophen: No Effect in Osteoarthritis Pain or Function
A network analysis of multiple therapies used in osteoarthritis found that acetaminophen (paracetamol) does not meet the minimum standard of clinical effectiveness in reducing pain or improving physical function in patients with knee and hip osteoarthritis.
Read ArticleMinimal Disease Activity Falls Short in Psoriatic Arthritis
A small cohort study has evaluated the utility of the minimal disease activity (MDA) criteria that has been advocated for use in psoriatic arthritis (PsA) studies and clinical trials.
Read ArticleIxekizumab Superior to Etanercept in Psoriasis
The UNCOVER-2 and UNCOVER-3 trials were presented at the American Academy of Dermatology (AAD) Annual Meeting taking this week in Washington, D.C.
Read ArticleVitamin D has No Effect on Knee Osteoarthritis
Vitamin D supplementation for individuals with knee osteoarthritis and low 25-hydroxyvitamin D levels did not reduce knee pain or slow cartilage loss, according to a study appearing in the March 8 issue of JAMA.
Intraarticular Steroids Before Joint Surgery Increase Infection Risk
Hip and knee intraarticular injection of corticosteroids are frequently prescribed to alleviate pain or inflammation in patients with osteoarthritis and rheumatoid arthritis, especially in the period leading up to scheduled arthroplasty.
Read ArticleTNF Inhibition and Heart Failure
Clinicians often face the issue of using a TNF inhibitor (TNFi) in patients with heart failure or cardiac disease. Here are the facts and data necessary to make a cogent decision to use or avoid TNFi.
Read ArticleLess Treatment, Responses and Safety in Elder-Onset Rheumatoid Arthritis
A recent review compared elderly-onset rheumatoid arthritis (EORA) to those with younger-onset rheumatoid arthritis (YORA) to assess treatment responses and safety issues with biologics and DMARDS. EORA is generally defined as the onset of rheumatoid arthritis after age 60 years.
Read ArticleSubclinical Synovitis in Psoriasis Portends Future Psoriatic Arthritis
It is estimated that nearly 30% of psoriasis patients will develop psoriatic arthritis (PsA). This prevalence was studied by performing MRI scans on asymptomatic psoriasis (n=56) and 30 control patients without arthritis.
Read ArticleTools, Brains & Organizers for Your Phone
Most people can’t live without their cell phone. But does the device define the modern medicine man and woman?
Read ArticleRheumatoid Arthritis Alone is Not a Risk for Post-Op CV Events
Using hospitalization claims from 7 states, reasearchers studied the risk of cardiovascular outcomes following surgery in rheumatoid arthritis (RA) patients. (Citation source http://buff.ly/1TDsVG6)
Read Article


